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Experience with inferior vena cava filter
placement in patients undergoing open gastric
bypass procedures
Nicholas J. Gargiulo III, MD, Frank J. Veith, MD, Evan C. Lipsitz, MD, William D. Suggs, MD,
Takao Ohki, MD, PhD, and Elliot Goodman, MD, Bronx, NY
Objective: Patients undergoing open gastric bypass (OGB) for morbid obesity are at significant risk for pulmonary
embolism (PE) despite the use of subcutaneous heparin injections and sequential compression devices. Prophylactic
preoperative inferior vena cava (IVC) filter placement may reduce this risk. We report our experience with simultaneous
IVC filter placement and OGB in an operating room setting.
Methods: From July 1999 to April 2001, 193 patients (group 1) underwent OGB. Eight patients had prophylactic
intraoperative IVC filters placed for deep vein thrombosis, PE, or pulmonary hypertension. From May 2001 to
January 2003, 181 patients (group 2) underwent OGB. There were 33 IVC filters placed for body mass index (BMI)
greater than 55 kg/m2 in addition to the above-mentioned criteria. To confirm observations made in group 1 and
2 patients, from July 2003 to May 2005, 197 patients (group 3) underwent OGB, and patients with a BMI greater
than 55 kg/m2 (n  35) were offered IVC filter placement. Group 3A (n  17) consented to IVC filter placement,
and group 3B (n  18) did not.
Results: Fifty-eight IVC filters were placed (100% technical success rate) with an increase in operating room time of 20
5 minutes. In group 1, the eight patients with IVC filters had a BMI greater than 55 kg/m2. There were four PEs (3 fatal
and 1 nonfatal) in the other 185 patients, all which occurred in patients with BMIs greater than 55 kg/m2. In group 2,
there were no PEs. The perioperative PE rate in these patients was reduced from 13% (4/31; 95% confidence interval [CI],
1.1%-25.7%) to 0% (0/33; 95% CI, 0%-8.7%). Perioperative mortality was reduced from 10% (3/31; 95% CI, 0%-20.0%)
to 0% (0/33; 95% CI, 0%-8.7%). There were no pulmonary emboli or deaths related to PE in group 3A patients. Group
3B patients had a 28% PE rate (two fatal and three nonfatal) and an 11% PE-related death rate. None of the remaining
patients in group 3 had a PE.
Conclusions: Intraoperative IVC filter placement for the prevention of PE in morbidly obese patients undergoing OGB is
feasible. We observed a significant reduction in the perioperative PE rate when a BMI greater than 55 kg/m2 was used
as an indication for IVC filter placement despite the use of subcutaneous heparin injections and sequential compression
devices. ( J Vasc Surg 2006;44:1301-5.)There has been a recent resurgence of interest in mor-
bid obesity surgery.1-4 Morbid obesity is defined as a body
mass index (BMI) greater than 40 kg/m2 or 100 pounds
over ideal body weight and is a major national health
concern.5 A recent national consensus concluded that the
number of obese individuals in the United States has in-
creased from 12% in 1990 to almost 20% in 1998.6,7 A
separate National Institutes of Health consensus panel con-
cluded that surgery is a viable option in patients with a BMI
greater than 40 kg/m2 and in patients with a BMI greater
than 35 kg/m2 and significant medical comorbidities or
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Initial reports on surgical weight loss procedures con-
cluded thatmorbidly obese patients with concomitant sleep
apnea syndrome or pulmonary hypertension have a higher
incidence of perioperative pulmonary embolism (PE).8
These observations were never formally evaluated in
prospective, randomized trials, nor were they addressed in
ongoing investigations of bariatric surgical weight loss pro-
cedures. The relatively high PE rate in our own initial
experience with surgical weight loss procedures prompted
us to review our data for these patients.
PE is a known but preventable cause of perioperative
death that may occur at any time, from during surgery to
several weeks after surgery. However, to date, there has
been no formal consensus or recommendations for the
prevention of PE in this young, high-risk group of patients
despite the growing popularity of these operations. Cur-
rently accepted practices for the prevention of PE include
perioperative subcutaneous heparin injections and sequen-
tial compression devices (SCDs). Inferior vena cava (IVC)
filter placement has been advocated in patients with a
history of deep venous thrombosis (DVT), PE, or pulmo-
nary hypertension. Although prophylactic IVC filter place-
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and challenging.
Our objectives in this study were to describe an intra-
operative technique of IVC filter placement in a high-risk
group of morbidly obese patients undergoing the open
Roux-en-Y gastric bypass procedure and to determine
whether IVC filter placement during open gastric bypass
(OGB) reduces the incidence of perioperative PE despite
the use of subcutaneous heparin injections and SCDs.
METHODS
Placement of IVC filter
All patients having IVC filters placed at the time of
open Roux-en-Y gastric bypass surgery had a BMI greater
than 55 kg/m2 and were placed on a Skytron (Skytron,
Grand Rapids, Mich) Heavy Duty 6500 fluoroscopic table,
which was reversed. A cephalad extension was added to the
“head” (original foot) of the table to permit imaging of the
patient’s abdomen. Imaging was performed by using a
portable GE (General Electric, Salt Lake City, Utah) OEC
9800 digital fluoroscope. A transfemoral percutaneous
puncture was made with an 18-gauge needle, and a Magic
Torque (Boston Scientific, Watertown, Mass) wire was
fluoroscopically guided into the IVC. The needle was then
exchanged for a 6F, 7F, or 12F sheath supplied by the
Trapease (Cordis, Warren, NJ), Simon-Nitinol (Nitinol
Medical Technologies, Boston, Mass), Greenfield (Boston
Scientific), or Bard Recovery (Nitinol Medical Technolo-
gies) IVC filter systems. Vena cavography was performed to
measure IVC diameter, confirm patency, and identify the
confluence of the iliac veins. Selective left and right renal
venography was then performed by using a Cobra 1 (C1)
catheter (Cook, Bloomington, Ind). A Trapease (n  35),
Simon-Nitinol (n 9), Greenfield (n 2), or Bard Recov-
ery (n  12) filter was then deployed into the infrarenal
IVC under fluoroscopic control. Completion venography
after IVC filter deployment confirmed the filter position
and the patency of the IVC and renal veins.
Study design
Group 1: retrospective review. We reviewed our bari-
atric surgery program’s early results from its inception in
July 1999 through April 2001. A retrospective analysis was
performed on 193 patients (group 1; average BMI, 51 
7 kg/m2) undergoing the open Roux-en-Y gastric bypass
procedure. During this initial 22-month period, indica-
tions for IVC filter placement included a history of DVT,
PE, or pulmonary hypertension (mean pulmonary artery
pressure 40 mm Hg) as measured by noninvasive echo-
cardiography or Swan-Ganz catheterization. These indica-
tions for IVC filter placement were based on prior work by
Sugerman et al.8 On the basis of these indications, eight
patients (4.1%) had IVC filters placed at the time of
operation.
Group 2: change in clinical practice. From May
2001 to January 2003, a prospective analysis was per-
formed on 181 patients (group 2; average, BMI 51  6kg/m2) undergoing the open Roux-en-Y gastric bypass
procedure. In this next 21-month period, according to our
experience with group 1, a BMI greater than 55 kg/m2 or
a history of DVT, PE, or pulmonary hypertension was used
as the indication for IVC filter placement. A BMI greater
than 55 kg/m2 was added as an additional indication for
IVC filter placement because despite our implementation
of prior work by Sugerman et al,8 four patients still had PEs.
Thirty-three patients (18%) had IVC filters placed at the
time of operation in this group.
Group 3: change in clinical practice. From July
2003 to May 2005, 197 patients (group 3; average BMI,
51 7 kg/m2) underwent OGB, and patients with a BMI
greater than 55 kg/m2 (n  35) were given the option of
IVC filter placement on the basis of our prior clinical
experience. Group 3A patients (n 17; average BMI, 63
5 kg/m2) underwent IVC filter placement with OGB, and
group 3B patients (n  18; average BMI, 63  5 kg/m2)
underwent OGB only, without IVC filter placement.
All patients in both groups had routine preoperative
and postoperative lower extremity venous duplex examina-
tion. One bariatric surgeon and three vascular surgeons
performed all of the OGB procedures and IVC filter place-
ments, respectively, in groups 1 and 2. Two bariatric sur-
geons and one vascular surgeon performed all of the OGB
procedures and IVC filter placements, respectively, in
group 3 patients.
Additionally, all of the patients received SCDs, throm-
boembolic devices (TEDs), and weight-adjusted subcuta-
neous heparin (50 U/kg) injections before surgery and
every 12 hours after surgery until they were ambulating
more than 4 h/d. Routine perioperative pulmonary an-
giography, spiral computed tomographic scanning, and
ventilation/perfusion scanning were not performed unless
the patients had clinical sequelae suggestive of a PE. PEs
were documented by spiral computed tomography, venti-
lation/perfusion scan, or autopsy within the perioperative
period (30 days after surgery).
Statistical analysis
For group 1 and 2 patients, data analysis was per-
formed with a 95% confidence interval (CI) by using SPSS
Software (SPSS Inc, Chicago, Ill). This data analysis was
used to demonstrate that a BMI greater than 55 kg/m2 was
an additional risk factor for having a PE during OGB in
addition to those previously described by Sugerman et al.8
It was also used to demonstrate the dramatic decrease in PE
when IVC filters are placed despite the use of subcutaneous
heparin injections and SCDs at the time of OGB in patients
with a BMI greater than 55 kg/m2.
The Fisher exact test was used to compare groups 1, 2,
3A, and 3B because all groups of patients had similar risk
factors, hypercoagulable profiles, and comorbidities. These
differences were calculated only by using patients with a
BMI greater than 55 kg/m2 and did not include the
remaining cohort of patients with lower BMIs. The only
difference in these two groups of patients was whether an
group
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icance was defined as P  .05.
RESULTS
All patient and group characteristics were similar
(Table I). Fifty-eight IVC filters were successfully placed in
the infrarenal IVC in 58 patients (100% technical success
rate). The average additional operating room time for IVC
filter placement was 20  5 minutes. The average fluoro-
scopic time was 3  1 minutes, and the average amount of
contrast used was 30  10 mL. There was minimal blood
loss, and there were no intraoperative complications. The
average length of follow-up was 2.5 years (range, 1-42
months).
Group 1: retrospective review. In the initial 22-
month period, 8 of the group 1 patients had a preoperative
IVC filter placed for a history of DVT (n 3), PE (n 2),
or documented pulmonary hypertension (n  3). Again,
these indications for IVC filter placement were based on
prior work by Sugerman et al.8 None of these eight patients
receiving IVC filters had a perioperative PE, and all had a
BMI greater than 55 kg/m2. Four patients in group 1 did
not meet criteria for IVC filter placement and developed a
fatal (n 3) or nonfatal (n 1) PE. All four patients had a
BMI greater than 55 kg/m2 and had risk factors, hyperco-
agulable profiles, and other comorbidities similar to others
in the group. All four patients received subcutaneous hep-
arin injections and SCDs. No other confounding variables
other than a BMI greater than 55 kg/m2 were identified to
explain the PEs. There were 31 patients in group 1 with a
Table I. Patient and group characteristics*
Variable Group 1 Grou
n 193 18
Female 133 12
Male 60 5
BMI, kg/m2 (mean  SD) 51  7 51 
PE/DVT 5
PULM HTN 3
Sleep apnea 33 2
Venous stasis 5
DM 53 4
HTN 54 4
BMI, Body mass index; PE/DVT, history of pulmonary embolism or deep ve
HTN, hypertension.
*Group 3A and group 3B totals were combined for statistical analysis with
Table II. PE-related morbidity and mortality rates of
patients with BMI greater than 55 kg/m2
Group n
BMI  55
kg/m2
IVC
filters PE rate
PE
mortality
1 193 31 8 13% 10%
2 181 33 33 0% 0%
PE, Pulmonary embolism; BMI, body mass index; IVC, inferior vena cava.BMI greater than 55 kg/m2. These patients had a 10-foldrisk for PE after OGB (relative risk, 10.2; 95% CI, 5.8-18)
as compared with patients with a BMI less than 55 kg/m2
undergoing OGB.
Group 2: change in clinical practice (prospective
review). In the subsequent 21-month period, 33 of the
group 2 patients had a BMI greater than 55 kg/m2. All 33
patients received an IVC filter at the time of OGB on the
basis of our observations in group 1 patients. Five patients
with a BMI greater than 55 kg/m2 also had a history of
DVT (n 2), PE (n 1), or pulmonary hypertension (n
2). There were no patients with a BMI less than 55 kg/m2
and a history of DVT, PE, or pulmonary hypertension.
None of the patients in group 2 undergoing OGB had a
perioperative PE.
The perioperative PE rate in patients undergoing Roux-
en-Y gastric bypass surgery was reduced from 13% (4/31;
95% CI, 1.1%-24.7%) to 0% (0/33; 95% CI, 0%-8.7%)
when a BMI greater than 55 kg/m2 was used as an indica-
tion for IVC filter placement (Table II). In addition, PE-
related death was reduced from 10% (3/31; 95% CI, 0%-
20.0%) to 0% (0/33; 95% CI, 0%-8.7%; Table II).
One postoperative IVC thrombosis occurred 4 months
after Trapease IVC filter placement. Two postoperative
localized, insertion-site DVTs occurred 3 months after
filter placement and were treated with anticoagulation.
Group 3: change in clinical practice. In a separate
22-month period, the 17 patients with a BMI greater than
55 kg/m2 (group 3A) who underwent OGB and IVC filter
placement had no perioperative PEs. This was in striking
contrast to the 18 patients with a BMI greater than 55
Group 3 Group 3A Group 3B
197 17 18
142 14 15
55 3 3
51  7 63  5 63  5
2 1 1
2 1 1
21 11 10
5 3 2
50 17 18
47 17 18
thrombosis; PULMHTN, pulmonary hypertension; DM, diabetes mellitus;
s 1 and 2.
Table III. PE-related morbidity and mortality rates of
patients with BMI greater than 55 kg/m2
Variable
BMI  55
kg/m2
IVC
filters PE rate
PE
mortality
Group 3A 17 17 0% 0%
Group 3B 18 0 28% 11%
PE, Pulmonary embolism; BMI, body mass index; IVC, inferior vena cava.p 2
1
7
4
6
3
2
8
7
7
8
nouskg/m2 (group 3B) undergoing OGB only without IVC
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an 11% PE mortality rate (P  .05; Table III). Two patients
in group 3 died from causes related to the gastric bypass
procedure; one died from an anastomotic leak, and the
other died from an internal hernia.
Overall morbidity and mortality. The overwhelm-
ing benefit of IVC filter placement in patients with a BMI
greater than 55 kg/m2 undergoing OGB is minimized by
the overall benefit IVC filter placement has on the entire
cohort. Overall morbidity and mortality for group 2 pa-
tients were reduced by 2.3% and 1.7%, respectively, when
compared with group 1 patients (Table IV).
DISCUSSION
Morbid obesity is a multisystemic disease. It affects
every organ system, including the cardiovascular, pulmo-
nary, endocrinologic, renal, integumentary, neurologic,
and musculoskeletal systems. Surgical weight loss proce-
dures can reverse many, if not all, of these comorbidities.6
With the growing prevalence of morbid obesity in the
United States, there has been a resurgence of interest in its
surgical correction.1-4 This surgery is typically performed in
relatively young, but high-risk, patients, who often expect
immediate weight loss without any surgical complications.
Unfortunately, because of the high-risk nature of the pa-
tient population, a significant number of associated com-
plications can occur that result in significant morbidity and
disappointment for the patients and their families.
PE is one of the most devastating complications, with
an incidence of 2% to 4% in morbidly obese patients under-
going OGB.9 Despite the use of subcutaneous heparin
injections, SCDs, and prior indications for IVC filter place-
ment by Sugerman et al,8 a significant number of PEs and
deaths from PEs was observed in our practice until we
began placing IVC filters in patients undergoing OGBwith
a BMI greater than 55 kg/m2. The PE rate was dramati-
cally reduced in the patients with a high body mass index—
again, those with a BMI greater than 55 kg/m2.
This benefit was not as profound when the entire
cohort of morbidly obese patients was analyzed. In fact, the
overall morbidity and mortality of all morbidly obese pa-
tients undergoing OGB surgery was minimally reduced.
There is no doubt, however, that a subgroup of morbidly
obese patients with high BMIs, ie, those with a BMI greater
than 55 kg/m2, improve their morbidity and mortality
remarkably when an IVC filter is placed.
Despite the benefits, the logistics of IVC filter place-
Table IV. PE-related and overall morbidity and
mortality rates
Group n
Overall PE
rate
Overall PE
mortality
Overall
morbidity
Overall
mortality
1 193 2.1% 1.6% 4.2% 2.1%
2 181 0% 0% 1.9% 0.6%
PE, Pulmonary embolism.ment in this group of patients are both numerous andchallenging. First, the patients’ obesity prevents their posi-
tioning on standard angiographic tables. Standard tables
in interventional radiology or cardiac catheterization suites
hold patients up to 350 to 400 pounds, whereas the Skytron
Heavy Duty 6500 operating room table holds patients up
to 800 pounds. In addition, the percutaneous femoral
puncture is cumbersome because of the massive abdominal
pannus. We circumvented this problem by using tincture of
benzoin and silk tape to retract the abdominal pannus for
improved access to the groin. Another possible access site
for IVC filter placement is the internal jugular vein, which
can be localized by using ultrasonography. This approach
was not used in these patients because most had previous
Swan-Ganz catheter and/or central venous pressure lines
placed. Because of the patients’ body habitus, the fluoro-
scopic images obtained are not as clear as those performed
in relatively thin patients, but the images provide adequate
visualization of the IVC, iliac, and renal veins for filter
placement. Selective catheterization of the left and right
renal veins ensured precise IVC deployment and helped
improve our visualization. By performing simultaneous
IVC filter placement and OGB, one eliminates the need for
an additional admission or day of hospitalization.
Over this 65-month study period, several types of IVC
filters were used. Most patients in this series received filters
with low-profile introducer sheaths. A lower-profile intro-
ducer sheath reduces the time needed for manual compres-
sion and decreases the risk of hematoma formation. It may
also reduce the incidence of insertion-site DVT. The long-
term patency and PE rate may help clarify the role of
retrievable IVC filters in this population. More recently, we
have used the Tulip (Cook), Optease (Cordis), and Bard
Recovery (Nitinol Medical Technologies) retrievable filters
in these procedures, with success.
IVC filter placement is not a completely benign proce-
dure. Early in our experience, there were two patients with
postoperative DVT on the side of venous puncture for IVC
filter insertion, and there was one IVC thrombosis 4
months after surgery. Both patients with postoperative
DVT presented 3 months after IVC filter placement with
lower extremity pain and edema and were diagnosed by
using duplex sonography. These patients were both treated
with intravenous heparin and subsequent warfarin therapy.
Neither patient developed a PE. The patient with IVC
thrombosis presented 1 week after the onset of symptoms
and was found to have a compartment syndrome in both
lower extremities necessitating bilateral fasciotomies. This
patient subsequently died after 2 months of hospitaliza-
tion from complications related to the gastric bypass
procedure.
This study demonstrates the efficacy and feasibility of
intraoperative IVC filter placement for the prevention of
PE in morbidly obese patients undergoing OGB surgery.
The procedure may be performed safely with a high tech-
nical success rate and minimal additional operating room
time. We observed a significant reduction in the perioper-
ative PE rate when a BMI greater than 55 kg/m2 was used
as a criterion for IVC filter placement. We recommend the
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prophylactic IVC filter placement in addition to the use of
subcutaneous heparin injections, SCDs, and the prior cri-
teria described by Sugerman et al8 in patients undergoing
OGB surgery. We encourage further prospective, random-
ized studies if there is still question about the benefit and if
other institutions are willing to participate.
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